Rid mousse
This article was originally published in The Tan Sheet
Executive Summary
Pfizer aerosol foam mousse lice treatment designated "approvable" in July 8 letter from FDA. Active ingredients are pyrethrins and piperonyl butoxide. Victoria, Australia-based Soltec Research, developer of a topical mousse delivery system, filed the original new drug application. Mousse formulation would join the Rid lice-control product line, which includes Maximum Strength Shampoo, Lice Control Spray, egg removal comb and Lice Egg Loosener Gel, which began shipping in mid-June (1"The Tan Sheet" June 21, p. 6)
You may also be interested in...
Pfizer Rid Mousse Pediculicide Approved Under "NDA Deviation"
FDA approved an "NDA Deviation" (21-043) for Pfizer's Maximum Strength Rid Mousse aerosolized foam lice treatment March 7. It is one of the first "NDA Deviations" to get the go-ahead from the agency; such an application is for a product that is comparable to products in a monograph but deviates in a significant way.
Pfizer Rid Mousse Pediculicide Approved Under "NDA Deviation"
FDA approved an "NDA Deviation" (21-043) for Pfizer's Maximum Strength Rid Mousse aerosolized foam lice treatment March 7. It is one of the first "NDA Deviations" to get the go-ahead from the agency; such an application is for a product that is comparable to products in a monograph but deviates in a significant way.
Pfizer Rid Mousse Pediculicide Approved Under "NDA Deviation"
FDA approved an "NDA Deviation" (21-043) for Pfizer's Maximum Strength Rid Mousse aerosolized foam lice treatment March 7. It is one of the first "NDA Deviations" to get the go-ahead from the agency; such an application is for a product that is comparable to products in a monograph but deviates in a significant way.